r detecting primarily lower gastrointestinal bleeding disorders that may
be related to iron deficiency anemia, diverticulitis, ulcerative colitis,
polyps, adenomas, colorectal cancers or other gastrointestinal lesions that
can bleed. Health professionals recommend FIT tests for use in screening
for colorectal cancer or other sources of lower gastrointestinal bleeding.
Enterix Inc. was acquired in August 2006, by Quest Diagnostics, and is a
wholly owned subsidiary of Quest Diagnostics Incorporated. Additional
information is available at:
http://www.insuretest.com.
About HemoCue
The HemoCue family of companies, acquired by Quest Diagnostics in 2007,
is a global leader in a field of diagnostics known as near patient, or
point-of-care, testing. In 1982, HemoCue AB, based in Angelholm, Sweden,
introduced the first system making accurate hemoglobin testing possible in
near-patient settings. Since then, more than 250,000 HemoCue systems have
been sold worldwide. The company also manufactures point-of-care tests for
glucose, urine albumin, and total white blood cell count. HemoCue
subsidiaries, affiliates, franchises, and third-party distributors generate
revenue in more than 100 countries, including England, Finland, Germany,
the Netherlands, Switzerland, Norway, Denmark, Sweden and the U.S. HemoCue,
Inc., is a U.S. distributor of products made by HemoCue AB and of the
InSure Quik F I T point-of-care fecal immunochemical test. Additional
company information is available at http://www.hemocue.com.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive
'/>"/>
SOURCE Quest Diagnostics Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs2.
Novozymes Launches Enzyme to Reduce Acrylamide in Food3.
Enova Medical Launches Exos Corporation4.
Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability5.
Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor6.
ThirdBiotech Networking Group Launches7.
BioReliance Launches Next-Generation Genotoxicity Screening Service8.
Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)9.
BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests10.
Kingfisher Healthcare Launches Breakthrough Product in Europe11.
Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany